WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2017> 28> 3

Volume: 28 Issue: 3

1. Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update. Page:e34—
2. Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. Page:e22—
3. An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016). Page:e26—
4. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma. Page:e28—
5. Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas. Page:e33—
6. Increased risk of breast cancer in women with uterine myoma: a nationwide, population-based, case-control study. Page:e35—
7. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. Page:e36—
8. Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study. Page:e37—
9. Surgical treatment of early ovarian cancer with compartmental resection of regional lymphatic network and indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, paraaortic part). Page:e41—
10. Major clinical research advances in gynecologic cancer in 2016: 10-year special edition. Page:e45—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.